Intrathecal corticosteroids might slow Alzheimer’s disease progression
Joseph Martin Alisky1,21Marshfield Clinic Research Foundation; 2Marshfield Clinic-Thorp Center, Marshfield, Wisconsin, USAAbstract: Anti-inflammatory drugs for treatment and prevention of Alzheimer’s disease have to date proved disappointing, including a large study of low-dose prednis...
Saved in:
Main Author: | Joseph Martin Alisky |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/a7bb9ad46b8e43bebd7a081728de5468 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An update on the toxicity of Aβ in Alzheimer’s disease
by: Jürgen Götz, et al.
Published: (2008) -
Update on the use of memantine in Alzheimer’s disease
by: Robert J van Marum
Published: (2009) -
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
by: Kristinsson J, et al.
Published: (2012) -
Brain amyloid β protein and memory disruption in Alzheimer’s disease
by: Weiming Xia
Published: (2010) -
Present and prospective clinical therapeutic regimens for Alzheimer’s disease
by: Mustafa M Husain, et al.
Published: (2008)